The DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.
Cholesterol 24-Hydroxylase: An Enzyme of Cholesterol Turnover in the Brain
Open accessAbstract
Cholesterol 24-hydroxylase is a highly conserved cytochrome P450 that is responsible for the majority of cholesterol turnover in the vertebrate central nervous system. The enzyme is expressed in neurons, including hippocampal and cortical neurons that are important for learning and memory formation. Disruption of the cholesterol 24-hydroxylase gene in the mouse reduces both cholesterol turnover and synthesis in the brain but does not alter steady-state levels of cholesterol in the tissue. The decline in synthesis reduces the flow of metabolites through the cholesterol biosynthetic pathway, of which one, geranylgeraniol diphosphate, is required for learning in the whole animal and for synaptic plasticity in vitro. This review focuses on how the link between cholesterol metabolism and higher-order brain function was experimentally established.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“When neurons require cholesterol turnover or accumulate too much cholesterol or its intermediates, the cytochrome P450 oxidase Cyp46a1 hydroxylates cholesterol to produce 24S-hydroxycholesterol (24SOHC), allowing for egress by one-way diffusion into the circulation across the BBB (Fig. 4a)31.”
From A suppressor screen in Mecp2 mutant mice implicates cholesterol metabolism in Rett syndrome (2013) · cites this paper as [31]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cholesterol turnover is also required to produce geranylgeraniol, a product of HMGCR upstream of SQLE that is essential for learning and synaptic plasticity31, and is important for the interaction between neurons and astrocytes at the synapse28.”
From A suppressor screen in Mecp2 mutant mice implicates cholesterol metabolism in Rett syndrome (2013) · cites this paper as [31]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Instead, astrocytes make cholesterol and transport it to neurons with apolipoprotein E (apoE) (25–27).”
From Regulation of beta-amyloid production in neurons by astrocyte-derived cholesterol (2021) · cites this paper as [26]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This catabolic pathway, which is facilitated by cholesterol 24-hydroxylase (CYP46A1), is the major route for eliminating cholesterol from the CNS, and is therefore a key player in the maintenance of cholesterol homeostasis in the brain (Lütjohann et al., 1996; Russell et al., 2009).”
From Suppression of brain cholesterol synthesis in male Mecp2-deficient mice is age dependent and not accompanied by a concurrent change in the rate of fatty acid synthesis (2017) · cites this paper as Russell et al., 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A synaptic model of memory: long-term potentiation in the hippocampus
Bliss, T. V. P., & Collingridge, G. L. (1993) · Nature · doi:10.1038/361031a0 · Cited by 11,566
Bliss, T. V. P., & Gardner-Medwin, A. R. (1973) · The Journal of Physiology · doi:10.1113/jphysiol.1973.sp010274 · Cited by 7,424
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280
Long-Term Potentiation--A Decade of Progress?
Malenka, R. C., & Nicoll, A. R. A. (1999) · Science · doi:10.1126/science.285.5435.1870 · Cited by 2,729
Calabrese, V. P. (1992) · JAMA · doi:10.1001/jama.1992.03490230111048 · Cited by 2,521
Apolipoprotein E: Far More Than a Lipid Transport Protein
Mahley, R. W., & Rall, S. C. (2000) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.1.1.507 · Cited by 1,836
Protein Sensors for Membrane Sterols
Goldstein, J. L., DeBose-Boyd, R. A., & Brown, M. S. (2006) · Cell · doi:10.1016/j.cell.2005.12.022 · Cited by 1,517
Endocannabinoid Signaling in the Brain
Wilson, R. I., & Nicoll, R. A. (2002) · Science · doi:10.1126/science.1063545 · Cited by 1,280
Structure and function of dendritic spines
Nimchinsky, E. A., Sabatini, B. L., & Svoboda, K. (2002) · Annual Review of Physiology · doi:10.1146/annurev.physiol.64.081501.160008 · Cited by 1,208
Dietschy, J. M., & Turley, S. D. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r400004-jlr200 · Cited by 1,095
Research works printed but not linked: 8
- Sokoloff L, 1976, Basic Neurochemistry, 388
- Begley DJ, 2003, Prog. Drug Res., 61, 39
- Turley SD, 1998, Am. J. Physiol., 274, E1099
- Ercoli A, 1953, Gazz. Chim. Ital., 83, 78
- van Lier JE, 1969, Tex. Rep. Biol. Med., 27, 167
- 10.3109/00365519609168296 · DOI
- McDonald JG, 2007, Methods Enzymol., 432, 143
- 10.1113/jphysiol.1973.sp010273 · DOI · Paper page
Cited by
Sorted by citations
Central Nervous System Lipoproteins: ApoE and Regulation of Cholesterol Metabolism
Mahley, R. W. (2016) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.116.307023 · Cited by 516
Cholesterol metabolism in neurons and astrocytes
Pfrieger, F. W., & Ungerer, N. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.06.002 · Cited by 500
The Concise Guide to PHARMACOLOGY 2013/14: Enzymes
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12451 · Cited by 425
Goldstone, J. V., McArthur, A. G., Kubota, A., Zanette, J., Parente, T. E., Jönsson, M. E., Nelson, D. R., & Stegeman, J. J. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-643 · Cited by 449
Myelin Fat Facts: An Overview of Lipids and Fatty Acid Metabolism
Poitelon, Y., Kopec, A. M., & Belin, S. (2020) · Cells · doi:10.3390/cells9040812 · Cited by 394
APOE and Alzheimer’s Disease: From Lipid Transport to Physiopathology and Therapeutics
Husain, M. A., Laurent, B., & Plourde, M. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.630502 · Cited by 353
Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases
Vance, J. E. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.010124 · Cited by 342
Cholesterol in brain disease: Sometimes determinant and frequently implicated
Martín, M. G., Pfrieger, F., & Dotti, C. G. (2014) · The EMBO Reports · doi:10.15252/embr.201439225 · Cited by 304
Regulation of beta-amyloid production in neurons by astrocyte-derived cholesterol
Wang, H., Kulas, J. A., Wang, C., Holtzman, D. M., Ferris, H. A., & Hansen, S. B. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2102191118 · Cited by 301
Paul, S. M., Doherty, J., Robichaud, A. J., Belfort, G. M., Chow, B. Y., Hammond, R., Crawford, D. C., Linsenbardt, A. J., Shu, H., Izumi, Y., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.2619-13.2013 · Cited by 276
A suppressor screen in Mecp2 mutant mice implicates cholesterol metabolism in Rett syndrome
Buchovecky, C. M., Turley, S. D., Brown, H. M., Kyle, S. M., McDonald, J. G., Liu, B., Pieper, A. A., Huang, W., Katz, D. M., Russell, D. W., et al. (2013) · Nature Genetics · doi:10.1038/ng.2714 · Cited by 234
Self-citationDjelti, F., Braudeau, J., Hudry, E., Dhenain, M., Varin, J., Bièche, I., Marquer, C., Chali, F., Ayciriex, S., Auzeil, N., et al. (2015) · Brain · doi:10.1093/brain/awv166 · Cited by 223
Oxysterols as biomarkers in neurodegenerative diseases
Leoni, V., & Caccia, C. (2011) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2011.04.002 · Cited by 229
Bryleva, E. Y., Rogers, M. A., Chang, C. C. Y., Buen, F., Harris, B. T., Rousselet, E., Seidah, N. G., Oddo, S., LaFerla, F. M., Spencer, T. A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913828107 · Cited by 209
Petrov, A. M., Kasimov, M. R., & Zefirov, A. L. (2016) · Acta Naturae · doi:10.32607/20758251-2016-8-1-58-73 · Cited by 202
Molecular basis of bile acid-FXR-FGF15/19 signaling axis
Katafuchi, T., & Makishima, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116046 · Cited by 193
Bile acid signaling in the regulation of whole body metabolic and immunological homeostasis
Jia, W. P., Li, Y., Cheung, K. C.-P., & Zheng, X. (2023) · Science China Life Sciences · doi:10.1007/s11427-023-2353-0 · Cited by 207
Diabetes and Insulin in Regulation of Brain Cholesterol Metabolism
Suzuki, R., Lee, K., Jing, E., Biddinger, S. B., McDonald, J. G., Montine, T. J., Craft, S., & Kahn, C. R. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.11.006 · Cited by 169
LXR Regulation of Brain Cholesterol: From Development to Disease
Courtney, R., & Landreth, G. E. (2016) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2016.03.018 · Cited by 190
Formation and function of apolipoprotein E-containing lipoproteins in the nervous system
Vance, J. E., & Hayashi, H. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.02.007 · Cited by 155
Egawa, J., Pearn, M. L., Lemkuil, B. P., Patel, P. M., & Head, B. P. (2015) · The Journal of Physiology · doi:10.1113/jp270590 · Cited by 184
Cholesterol metabolism in the brain and its association with Parkinson’s disease.
Jin, U., Park, S. J., & Park, S. M. (2019) · Experimental Neurobiology · doi:10.5607/en.2019.28.5.554 · Cited by 169
Defective cholesterol metabolism in amyotrophic lateral sclerosis
Abdel‐Khalik, J., Yutuc, E., Crick, P. J., Gustafsson, J.-Α., Warner, M. N., Román, G. C., Talbot, K., Gray, E., Griffiths, W. J., Turner, M. R., et al. (2016) · Journal of Lipid Research · doi:10.1194/jlr.p071639 · Cited by 173
Rogers, M. A., Liu, J., Song, B., Li, B.-L., Chang, C. C. Y., & Chang, T. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.09.008 · Cited by 167
Cellular cholesterol homeostasis and Alzheimer’s disease
Chang, T.-Y., Yamauchi, Y., Hasan, M. T., & Chang, C. (2017) · Journal of Lipid Research · doi:10.1194/jlr.r075630 · Cited by 155
Guengerich, F. P. (2015) · Springer eBooks · doi:10.1007/978-3-319-12108-6_9 · Cited by 159
Cell cholesterol homeostasis: Mediation by active cholesterol
Steck, T. L., & Lange, Y. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.08.007 · Cited by 139
Mast, N., Annalora, A. J., Lodowski, D. T., Palczewski, K., Stout, C. D., & Pikuleva, I. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.188433 · Cited by 138
Guengerich, F. P. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00226 · Cited by 143
Rodríguez, I. R., & Larráyoz, I. M. (2010) · Journal of Lipid Research · doi:10.1194/jlr.r004820 · Cited by 134
The Role of Cholesterol in α‐Synuclein and Lewy Body Pathology in GBA1 Parkinson's Disease
García‐Sanz, P., Aerts, J. M. F. G., & Moratalla, R. (2020) · Movement Disorders · doi:10.1002/mds.28396 · Cited by 126
The impairment of cholesterol metabolism in Huntington disease
Leoni, V., & Caccia, C. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.12.018 · Cited by 122
Marked accumulation of 27-hydroxycholesterol in SPG5 patients with hereditary spastic paresis
Schüle, R., Siddique, T., Deng, H., Yang, Y., Donkervoort, S. C., Hansson, M. E. A., Madrid, R. E., Siddique, N., Schöls, L. J., & Björkhem, I. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m002543 · Cited by 124
Nakano, M., Kelly, E. J., Wiek, C., Hanenberg, H., & Rettie, A. E. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.080085 · Cited by 114
ACAT1/SOAT1 as a Therapeutic Target for Alzheimer's Disease
Shibuya, Y., Chang, C. C., & Chang, T.-Y. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.161 · Cited by 113
24S-hydroxycholesterol in plasma: A marker of cholesterol turnover in neurodegenerative diseases
Leoni, V., & Caccia, C. (2012) · Biochimie · doi:10.1016/j.biochi.2012.09.025 · Cited by 124
Shibuya, Y., Chang, C. C. Y., Huang, L.-H., Bryleva, E. Y., & Chang, T.-Y. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.2567-14.2014 · Cited by 108
“Under normal condition, Cyp46 A1 is a neuron-specific enzyme (Russell et al., 2009).”
BackgroundMast, N., Saadane, A., Valencia‐Olvera, A. C., Constans, J., Maxfield, E., Arakawa, H., Li, Y., Landreth, G. E., & Pikuleva, I. A. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.06.026 · Cited by 111
Cytochromes P450: Roles in Diseases
Pikuleva, I. A., & Waterman, M. R. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.r112.431916 · Cited by 106
The effects of cholesterol on learning and memory
Schreurs, B. G. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.04.010 · Cited by 114
Shafaati, M., Marutle, A., Pettersson, H. I., Lövgren‐Sandblom, A., Olin, M., Pikuleva, I. A., Winblad, B. G., Nordberg, A. K., & Björkhem, I. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m014548 · Cited by 102
Cholesterol 24-Hydroxylation by CYP46A1: Benefits of Modulation for Brain Diseases
Petrov, A. M., & Pikuleva, I. A. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00731-6 · Cited by 113
ATAD3A oligomerization promotes neuropathology and cognitive deficits in Alzheimer’s disease models
Zhao, Y., Hu, D., Wang, R., Sun, X., Ropelewski, P., Hubler, Z. M. L., Lundberg, K. C., Wang, Q., Adams, D., Xu, R., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28769-9 · Cited by 98
Mast, N., Reem, R. E., Bederman, I. R., Huang, S., DiPatre, P. L., Björkhem, I., & Pikuleva, I. A. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-6021 · Cited by 97
Yutuc, E., Angelini, R., Baumert, M., Mast, N., Pikuleva, I. A., Newton, J., Clench, M. R., Skibinski, D. O. F., Howell, O. W., Wang, Y., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1917421117 · Cited by 95
Genetic connections between neurological disorders and cholesterol metabolism
Björkhem, I., Leoni, V., & Meaney, S. (2010) · Journal of Lipid Research · doi:10.1194/jlr.r006338 · Cited by 94
Yamanaka, K., Urano, Y., Takabe, W., Saito, Y., & Noguchi, N. (2014) · Cell Death and Disease · doi:10.1038/cddis.2013.524 · Cited by 93
Cholesterol loss during glutamate‐mediated excitotoxicity
Sodero, A. O., Vriens, J., Ghosh, D., Stegner, D., Brachet, A., Pallotto, M., Sassoé‐Pognetto, M., Brouwers, J. F. H. M., Helms, J. B., Nieswandt, B., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.31 · Cited by 100
24(S)-Hydroxycholesterol as a Modulator of Neuronal Signaling and Survival
Sun, M., Linsenbardt, A. J., Emnett, C. M., Eisenman, L. N., Izumi, Y., Zorumski, C. F., & Mennerick, S. J. (2015) · The Neuroscientist · doi:10.1177/1073858414568122 · Cited by 94
Véjux, A., Abed-Vieillard, D., Hajji, K., Zarrouk, A., Mackrill, J. J., Ghosh, S., Nury, T., Yammine, A., Zaibi, M. S., Mihoubi, W., et al. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.113648 · Cited by 92
Extra-virgin olive oil for potential prevention of Alzheimer disease
Román, G. C., Jackson, R. E., Reis, J. J., Roman, A., Toledo, J. B., & Toledo, E. (2019) · Revue Neurologique · doi:10.1016/j.neurol.2019.07.017 · Cited by 95
Petrov, A. M., Lam, M., Mast, N., Moon, J., Li, Y., Maxfield, E., & Pikuleva, I. A. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00737-0 · Cited by 86
Different oxysterols have opposing actions at N-methyl-d-aspartate receptors
Linsenbardt, A. J., Taylor, A., Emnett, C. M., Doherty, J., Krishnan, K., Covey, D. F., Paul, S. M., Zorumski, C. F., & Mennerick, S. J. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.05.027 · Cited by 85
Pharmacologic Stimulation of Cytochrome P450 46A1 and Cerebral Cholesterol Turnover in Mice
Mast, N., Li, Y., Linger, M., Clark, M., Wiseman, J. S., & Pikuleva, I. A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.532846 · Cited by 85
Nóbrega, C., Mendonça, L. S., Marcelo, A., Lamazière, A., Tomé, S. O., Després, G., Matos, C. A., Mechmet, F., Langui, D., den Dunnen, W. F. A., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02019-7 · Cited by 86
24S‐hydroxycholesterol: Cellular effects and variations in brain diseases
Sodero, A. O. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15228 · Cited by 84
Okabe, A., Urano, Y., Itoh, S., Suda, N., Kotani, R., Nishimura, Y., Saito, Y., & Noguchi, N. (2013) · Redox Biology · doi:10.1016/j.redox.2013.11.007 · Cited by 84
Cholesterol Hydroxylating Cytochrome P450 46A1: From Mechanisms of Action to Clinical Applications
Pikuleva, I. A., & Cartier, N. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.696778 · Cited by 91
Lipid Metabolism and Glial Lipoproteins in the Central Nervous System
Hayashi, H. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.453 · Cited by 80
Zarrouk, A., Véjux, A., Nury, T., Hajj, H. I. E., Haddad, M., Cherkaoui‐Malki, M., Riedinger, J., Hammami, M., & Lizard, G. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/623257 · Cited by 94
Maioli, S., Båvner, A., Ali, Z., Heverin, M., Ismail, M.-A.-M., Puerta, E., Olin, M., Saeed, A., Shafaati, M., Parini, P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068534 · Cited by 85
Halford, R. W., & Russell, D. W. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813349106 · Cited by 75
Self-citationGeoffroy, C., Paoletti, P., & Mony, L. (2021) · The Journal of Physiology · doi:10.1113/jp280875 · Cited by 73
Zhao, Q., Li, J., Feng, J., Wang, X., Liu, Y., Wang, F., Liu, L., Jin, B., Lin, M. S., Wang, Y., et al. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01379-7 · Cited by 86
Abnormal vascularization in mouse retina with dysregulated retinal cholesterol homeostasis
Omarova, S., Charvet, C. D., Reem, R. E., Mast, N., Zheng, W., Huang, S., Peachey, N. S., & Pikuleva, I. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63816 · Cited by 73
Molecular Regulation of Bile Acid Homeostasis
Choudhuri, S., & Klaassen, C. D. (2021) · Drug Metabolism and Disposition · doi:10.1124/dmd.121.000643 · Cited by 79
Cholesterol 24-hydroxylase: Brain cholesterol metabolism and beyond
Moutinho, M., Nunes, M. J., & Rodrigues, E. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.09.011 · Cited by 76
Current Insights Into Oligodendrocyte Metabolism and Its Power to Sculpt the Myelin Landscape
Narine, M., & Colognato, H. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.892968 · Cited by 81
Mast, N., Charvet, C. D., Pikuleva, I. A., & Stout, C. D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.143313 · Cited by 72
Cholesterol metabolism pathways – are the intermediates more important than the products?
Wang, Y., Yutuc, E., & Griffiths, W. J. (2021) · FEBS Journal · doi:10.1111/febs.15727 · Cited by 72
Gut microbiota modulation in Alzheimer's disease: Focus on lipid metabolism
Bonfili, L., Cuccioloni, M., Gong, C., Cecarini, V., Spina, M., Zheng, Y., Angeletti, M., & Eleuteri, A. M. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2022.01.025 · Cited by 69
Gene losses in the common vampire bat illuminate molecular adaptations to blood feeding
Blumer, M., Brown, T., Freitas, M. B., Destro, A. L., Oliveira, J. A., Morales, A. E., Schell, T., Greve, C., Pippel, M., Jebb, D., et al. (2022) · Science Advances · doi:10.1126/sciadv.abm6494 · Cited by 65
Diverse functions of 24(S)-hydroxycholesterol in the brain
Noguchi, N., Saito, Y., & Urano, Y. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.02.010 · Cited by 67
Pleiotropic effects of statins on brain cells
Sodero, A. O., & Barrantes, F. J. (2020) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2020.183340 · Cited by 69
Hughes, T. M., Kuller, L. H., López, O. L., Becker, J. T., Evans, R. G., Sutton-Tyrrell, K., & Rosano, C. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111460 · Cited by 64
Urano, Y., Ochiai, S., & Noguchi, N. (2013) · The FASEB Journal · doi:10.1096/fj.13-231456 · Cited by 75
Endogenous 24S-hydroxycholesterol modulates NMDAR-mediated function in hippocampal slices
Sun, M., Izumi, Y., Benz, A. M., Zorumski, C. F., & Mennerick, S. J. (2015) · Journal of Neurophysiology · doi:10.1152/jn.00890.2015 · Cited by 64
Lim, D., Jeong, J., & Song, J. (2021) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13653 · Cited by 64
Cholesterol metabolism in aging simultaneously altered in liver and nervous system
Nunes, V. S., Ferreira, G. D. S., & Quintão, E. C. R. (2022) · Aging · doi:10.18632/aging.203880 · Cited by 67
Cholesterol homeostasis in the vertebrate retina: biology and pathobiology
Rao, S. R., & Fliesler, S. J. (2020) · Journal of Lipid Research · doi:10.1194/jlr.tr120000979 · Cited by 62
Hawkins, N. A., Jurado, M., Thaxton, T. T., Duarte, S., Barse, L. W., Tatsukawa, T., Yamakawa, K., Nishi, T., Kondo, S., Miyamoto, M., et al. (2021) · Epilepsia · doi:10.1111/epi.17062 · Cited by 61
Czuba, E., Steliga, A., Lietzau, G., & Kowiański, P. (2017) · Metabolic Brain Disease · doi:10.1007/s11011-017-0015-3 · Cited by 62
Choquet, H., Trapani, E., Goitre, L., Trabalzini, L., Akers, A. L., Fontanella, M. M., Hart, B. L., Morrison, L. A., Pawlikowska, L., Kim, H., et al. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.01.008 · Cited by 59
Lipid mediators in the nucleus: Their potential contribution to Alzheimer's disease
Farooqui, A. A., Ong, W., & Farooqui, T. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.02.002 · Cited by 60
Changes in Brain Cholesterol Metabolome After Excitotoxicity
Ong, W., Kim, J., He, X., Chen, P., Farooqui, A. A., & Jenner, A. M. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8099-3 · Cited by 60
Effects of Oxysterols on Immune Cells and Related Diseases
de Freitas, F. A., Levy, D., Reichert, C. O., Cunha‐Neto, E., Kalil, J. E., & Bydlowski, S. P. (2022) · Cells · doi:10.3390/cells11081251 · Cited by 58
Central nervous system cholesterol metabolism in health and disease
Ho, W. Y., Hartmann, H., & Ling, S. (2022) · IUBMB Life · doi:10.1002/iub.2662 · Cited by 58
Lavrnja, I., Smiljanic, K., Savic, D., Mladenovic-Djordjevic, A., Tesovic, K., Kanazir, S., & Pekovic, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-02638-8 · Cited by 54
Oxysterols in the brain of the cholesterol 24-hydroxylase knockout mouse
Meljon, A., Wang, Y., & Griffiths, W. J. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.01.153 · Cited by 58
Izumi, Y., Cashikar, A. G., Krishnan, K., Paul, S. M., Covey, D. F., Mennerick, S. J., & Zorumski, C. F. (2021) · The Journal of Neuroscience · doi:10.1523/jneurosci.1502-21.2021 · Cited by 53
Phosphatidylcholine: Greasing the Cholesterol Transport Machinery
Lagace, T. A. (2015) · Lipid Insights · doi:10.4137/lpi.s31746 · Cited by 55
Rendić, S., & Guengerich, F. P. (2018) · Drug Metabolism Reviews · doi:10.1080/03602532.2018.1483401 · Cited by 54
The mevalonate pathway in neurons: It's not just about cholesterol
Moutinho, M., Nunes, M. J., & Rodrigues, E. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.02.034 · Cited by 57
Halford, J. J., Sperling, M. R., Arkilo, D., Asgharnejad, M., Zinger, C., Xu, R., During, M. J., & French, J. A. (2021) · Epilepsy Research · doi:10.1016/j.eplepsyres.2021.106646 · Cited by 51
Sterol Metabolism and Transport in Atherosclerosis and Cancer
Yamauchi, Y., & Rogers, M. A. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00509 · Cited by 52
Discovery of Soticlestat, a Potent and Selective Inhibitor for Cholesterol 24-Hydroxylase (CH24H)
Koike, T., Yoshikawa, M., Ando, H. K., Farnaby, W., Nishi, T., Watanabe, E., Yano, J. K., Miyamoto, M., Kondo, S., Ishii, T., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00864 · Cited by 48
The translational potential of cholesterol-based therapies for neurological disease
Valenza, M., Birolini, G., & Cattaneo, E. F. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00864-5 · Cited by 48
Theofilopoulos, S., de Oliveira, W. A. A., Yang, S., Yutuc, E., Saeed, A., Abdel‐Khalik, J., Ullgren, A., Cedazo-Mı́nguez, Á., Björkhem, I., Wang, Y., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005639 · Cited by 46
Rudajev, V., & Novotný, J. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01127-y · Cited by 52
Binding of a Cyano- and Fluoro-containing Drug Bicalutamide to Cytochrome P450 46A1
Mast, N., Zheng, W., Stout, C. D., & Pikuleva, I. A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.438754 · Cited by 45
Metadata
- Authors
- Russell, D. W., Halford, R. W., Ramirez, D. M. O., Shah, R., & Kotti, T.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Venue
- Annual Review of Biochemistry
- Publisher
- Annual Reviews
- Published
- 2009-06-01
- Volume
- 78
- Issue
- 1
- Pages
- 1017-1040
- ISSN
- 0066-4154 (ISSN-L)
- 1545-4509
- PMC
- PMC2837268
- OpenAlex
- W2128990583
- Cited by
- 317
- References
- 113
- Citations by year
- 2026: 11 · 2025: 18 · 2024: 27 · 2023: 16 · 2022: 23 · 2021: 40 · 2020: 26 · 2019: 20 · 2018: 16 · 2017: 12 · 2016: 18 · 2015: 14 · 2014: 13 · 2013: 13 · 2012: 16
- FWCI
- 2.66
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Annual Review of Biochemistry (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Welch Foundation
- National Institutes of Health
- National Heart, Lung, and Blood Institute (HL-20948, P01HL020948)
- National Institute of General Medical Sciences (GM 69338, U54GM069338)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 81182, PL1DK081182)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Physical Sciences › Chemistry › Organic Chemistry › Steroid Chemistry and Biochemistry
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Plant biochemistry and biosynthesis
- Keywords
- cholesterol 24-hydroxylase, cholesterol turnover, brain cholesterol metabolism, cytochrome P450, cholesterol biosynthesis, learning and memory, synaptic plasticity, hippocampal neurons, cortical neurons
- MeSH terms
- Cholesterol 24-Hydroxylase, Animals, Brain, Cholesterol, Hippocampus, Humans, Learning, Neurons, Steroid Hydroxylases, Gene Expression Regulation, Enzymologic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
